Peri‐operative management of anticoagulation and antiplatelet therapy

s), 122, 3588. Rossini, R., Musumeci, G., Visconti, L.O., Bramucci, E., Castiglioni, B., De Servi, S., Lettieri, C., Lettino, M., Piccaluga, E., Savonitto, S., Trabattoni, D., Capodanno, D., Buffoli, F., Parolari, A., Dionigi, G., Boni, L., Biglioli, F., Valdatta, L., Droghetti, A., Bozzani, A., Setacci, C., Ravelli, P., Crescini, C., Staurenghi, G., Scarone, P., Francetti, L., D’Angelo, F., Gadda, F., Comel, A., Salvi, L., Lorini, L., Antonelli, M., Bovenzi, F., Cremonesi, A., Angiolillo, D.J. & Guagliumi, G. (2014) Perioperative management of antiplatelet therapy in patients with coronary stents undergoing cardiac and non-cardiac surgery: a consensus document from Italian cardiological, surgical and anaesthesiological societies. EuroIntervention, 10, 38–46. Rossini, R., Musumeci, G., Capodanno, D., Lettieri, C., Limbruno, U., Tarantini, G., Russo, N., Guideline 612 a 2016 John Wiley & Sons Ltd British Journal of Haematology, 2016, 175, 602–613 Calabria, P., Romano, M., Inashvili, A., Sirbu, V., Guagliumi, G., Valsecchi, O., Senni, M., Gavazzi, A. & Angiolillo, D.J. (2015) Perioperative management of oral antiplatelet therapy and clinical outcomes in coronary stent patients undergoing surgery: results of a multicentre registry. Thrombosis and Haemostasis, 113, 272–282. Savonitto, S., Caracciolo, M., Cattaneo, M. & De Servi, S. (2011) Management of patients with recently implanted coronary stents on dual antiplatelet therapy who need to undergo major surgery. Journal of Thrombosis & Haemostasis, 9, 2133–2142. Schulman, S., Hwang, H.G., Eikelboom, J.W., Kearon, C., Pai, M. & Delaney, J. (2014) Loading dose vs. maintenance dose of warfarin for reinitiation after invasive procedures: a randomized trial. Journal of Thrombosis and Haemostasis, 12, 1254–1259. Schulman, S., Carrier, M., Lee, A.Y., Shivakumar, S., Blostein, M., Spencer, F.A., Solymoss, S., Barty, R., Wang, G., Heddle, N. & Douketis, J.D.; Periop Dabigatran Study Group. (2015) Perioperative Management of Dabigatran: A Prospective Cohort Study. Circulation, 132, 167–173. Shakur, H., Roberts, I., Bautista, R., Caballero, J., Coats, T., Dewan, Y., El-Sayed, H., Gogichaishvili, T., Gupta, S., Herrera, J., Hunt, B., Iribhogbe, P., Izurieta, M., Khamis, H., Komolafe, E., Marrero, M.A., Mejia-Mantilla, J., Miranda, J., Morales, C., Olaomi, O., Olldashi, F., Perel, P., Peto, R., Ramana, P.V., Ravi, R.R. & Yutthakasemsunt, S. (2010) Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial. Lancet, 376, 23–32. Sherwood, M.W., Douketis, J.D., Patel, M.R., Piccini, J.P., Hellkamp, A.S., Lokhnygina, Y., Spyropoulos, A.C., Hankey, G.J., Singer, D.E., Nessel, C.C., Mahaffey, K.W., Fox, K.A., Califf, R.M. & Becker, R.C. (2014) Outcomes of temporary interruption of rivaroxaban compared with warfarin in patients with nonvalvular atrial fibrillation: results from the rivaroxaban once daily, oral, direct factor Xa inhibition compared with vitamin K antagonism for prevention of stroke and embolism trial in atrial fibrillation (ROCKET AF). Circulation, 129, 1850–1859. Shi, J., Ji, H., Ren, F., Wang, G., Xu, M., Xue, Y., Chen, M., Qi, J. & Li, L. (2013) Protective effects of tranexamic acid on clopidogrel before coronary artery bypass grafting: a multicenter randomized trial. JAMA Surgery, 148, 538–547. Siegal, D., Yudin, J., Kaatz, S., Douketis, J.D., Lim, W. & Spyropoulos, A.C. (2012) Periprocedural heparin bridging in patients receiving vitamin K antagonists: systematic review and meta-analysis of bleeding and thromboembolic rates. Circulation, 126, 1630–1639. Siegal, D.M., Curnutte, J.T., Connolly, S.J., Lu, G., Conley, P.B., Wiens, B.L., Mathur, V.S., Castillo, J., Bronson, M.D., Leeds, J.M., Mar, F.A., Gold, A. & Crowther, M.A. (2015) Andexanet Alfa for the Reversal of Factor Xa Inhibitor Activity. New England Journal of Medicine, 373, 2413–2424. Singla, S., Sachdeva, R. & Uretsky, B.F. (2012) The risk of adverse cardiac and bleeding events following noncardiac surgery relative to antiplatelet therapy in patients with prior percutaneous coronary intervention. Journal of the American College of Cardiology, 60, 2005–2016. Smith, P.K., Goodnough, L.T., Levy, J.H., Poston, R.S., Short, M.A., Weerakkody, G.J. & Lenarz, L.A. (2012) Mortality benefit with prasugrel in the TRITON-TIMI 38 coronary artery bypass grafting cohort: risk-adjusted retrospective data analysis. Journal of the American College of Cardiology, 60, 388–396. Soo, C.G., Torre, P.K., Yolland, T.J. & Shatwell, M.A. (2016) Clopidogrel and hip fractures, is it safe? A systematic review and meta-analysis. BMC Musculoskeletal Disorders, 17, 136. Sorensen, R., Hansen, M.L., Abildstrom, S.Z., Hvelplund, A., Andersson, C., Jorgensen, C., Madsen, J.K., Hansen, P.R., Kober, L., TorpPedersen, C. & Gislason, G.H. (2009) Risk of bleeding in patients with acute myocardial infarction treated with different combinations of aspirin, clopidogrel, and vitamin K antagonists in Denmark: a retrospective analysis of nationwide registry data. Lancet, 374, 1967–1974. Sousa-Uva, M., Storey, R., Huber, K., Falk, V., Leite-Moreira, A.F., Amour, J., Al-Attar, N., Ascione, R., Taggart, D. & Collet, J.P. (2014) Expert position paper on the management of antiplatelet therapy in patients undergoing coronary artery bypass graft surgery. European Heart Journal, 35, 1510–1514. Spyropoulos, A.C. & Douketis, J.D. (2012) How I treat anticoagulated patients undergoing an elective procedure or surgery. Blood, 120, 2954– 2962. Steib, A., Barre, J., Mertes, M., Morel, M.H., Nathan, N., Ozier, Y., Treger, M. & Samama, C.M. (2010) Can oral vitamin K before elective surgery substitute for preoperative heparin bridging in patients on vitamin K antagonists? Journal of Thrombosis & Haemostasis, 8, 499– 503. Thiele, T., Sumnig, A., Hron, G., Muller, C., Althaus, K., Schroeder, H.W. & Greinacher, A. (2012) Platelet transfusion for reversal of dual antiplatelet therapy in patients requiring urgent surgery: a pilot study. Journal of Thrombosis and Haemostasis, 10, 968–971. Veitch, A.M., Vanbiervliet, G., Gershlick, A.H., Boustiere, C., Baglin, T.P., Smith, L.A., Radaelli, F., Knight, E., Gralnek, I.M., Hassan, C. & Dumonceau, J.M. (2016) Endoscopy in patients on antiplatelet or anticoagulant therapy, including direct oral anticoagulants: British Society of Gastroenterology (BSG) and European Society of Gastrointestinal Endoscopy (ESGE) guidelines. Gut, 65, 374–389. Vilahur, G., Choi, B.G., Zafar, M.U., Viles-Gonzalez, J.F., Vorchheimer, D.A., Fuster, V. & Badimon, J.J. (2007) Normalization of platelet reactivity in clopidogrel-treated subjects. Journal of Thrombosis & Haemostasis, 5, 82–90. Ward, C., Conner, G., Donnan, G., Gallus, A. & McRae, S. (2013) Practical management of patients on apixaban: a consensus guide. Thrombosis Journal, 11, 27. Guideline a 2016 John Wiley & Sons Ltd 613 British Journal of Haematology, 2016, 175, 602–613